Literature DB >> 22134597

Spectral- and time-domain optical coherence tomography measurements of macular thickness in normal eyes and in eyes with diabetic macular edema.

M A Ibrahim1, Y J Sepah, R C A Symons, R Channa, E Hatef, A Khwaja, M Bittencourt, J Heo, D V Do, Q D Nguyen.   

Abstract

PURPOSE: To report macular thickness values in normal eyes and eyes with diabetic macular edema (DME) using time-domain (TD) and spectral-domain (SD) optical coherence tomography (OCT), and to derive a conversion equation.
METHODS: The index study was a prospective investigation conducted on 80 eyes from 40 normal subjects and 130 eyes from 118 patients with DME seen in our clinic. Retinal thickness values from the central 1 mm of the macula and surrounding four ETDRS subfields were acquired using TD-OCT (Stratus OCT) and SD-OCT (SPECTRALIS HRA+OCT). Measurements of the central (C) subfield from both devices were used to derive a conversion equation. The equation was used to predict SD-OCT values using measurements from TD-OCT. Agreement between predicted and actual SD-OCT measurements was assessed.
RESULTS: In normal eyes, the mean difference between TD-OCT and SD-OCT measurements of the C subfield was 76 μm (CI(95)=74 and 77, respectively). The conversion equation, y=1.029x+72.49, was derived. In eyes with DME, using the equation, SPECTRALIS-predicted values were 5% higher than actual measurements, with 95% of predicted values falling within 9% of the actual measurements. Relocating SD-OCT grids to match the location on TD-OCT resulted in predicted values falling within 7% of actual measurements.
CONCLUSIONS: The percent difference between actual thickness measurements from SPECTRALIS and predicted thickness measurements, using the conversion equation, was within reported limits of repeatability of Stratus in eyes with DME. Our equation may help correlate OCT values from both devices in standard care and clinical trials for DME.

Entities:  

Mesh:

Year:  2011        PMID: 22134597      PMCID: PMC3298977          DOI: 10.1038/eye.2011.293

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  18 in total

1.  Retinal thickness and volume measurements in diabetic macular edema: a comparison of four optical coherence tomography systems.

Authors:  Jan Lammer; Christoph Scholda; Christian Prünte; Thomas Benesch; Ursula Schmidt-Erfurth; Matthias Bolz
Journal:  Retina       Date:  2011-01       Impact factor: 4.256

2.  Wavelength-tuning interferometry of intraocular distances.

Authors:  F Lexer; C K Hitzenberger; A F Fercher; M Kulhavy
Journal:  Appl Opt       Date:  1997-09-01       Impact factor: 1.980

3.  Optical frequency-domain reflectometry using rapid wavelength tuning of a Cr4+:forsterite laser.

Authors:  B Golubovic; B E Bouma; G J Tearney; J G Fujimoto
Journal:  Opt Lett       Date:  1997-11-15       Impact factor: 3.776

4.  Performance of fourier domain vs. time domain optical coherence tomography.

Authors:  R Leitgeb; C Hitzenberger; Adolf Fercher
Journal:  Opt Express       Date:  2003-04-21       Impact factor: 3.894

5.  Comparison of spectral- and time-domain optical coherence tomography for retinal thickness measurements in healthy and diseased eyes.

Authors:  Ian C Han; Glenn J Jaffe
Journal:  Am J Ophthalmol       Date:  2009-02-06       Impact factor: 5.258

6.  Correlation in foveal thickness measurements between spectral-domain and time-domain optical coherence tomography in normal individuals.

Authors:  P Carpineto; M Nubile; L Toto; A Aharrh Gnama; L Marcucci; L Mastropasqua; M Ciancaglini
Journal:  Eye (Lond)       Date:  2009-04-24       Impact factor: 3.775

7.  Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography.

Authors:  Christopher Kai-shun Leung; Carol Yim-lui Cheung; Robert N Weinreb; Gary Lee; Dusheng Lin; Chi Pui Pang; Dennis S C Lam
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

8.  Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema.

Authors:  Farzin Forooghian; Catherine Cukras; Catherine B Meyerle; Emily Y Chew; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-30       Impact factor: 4.799

9.  Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments.

Authors:  Ute E K Wolf-Schnurrbusch; Lala Ceklic; Christian K Brinkmann; Milko E Iliev; Manuel Frey; Simon P Rothenbuehler; Volker Enzmann; Sebastian Wolf
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

10.  Comparison of retinal thickness in normal eyes using Stratus and Spectralis optical coherence tomography.

Authors:  Sandeep Grover; Ravi K Murthy; Vikram S Brar; Kakarla V Chalam
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-10       Impact factor: 4.799

View more
  22 in total

1.  Macular ischemia and outcome of vitrectomy for diabetic macular edema.

Authors:  Jaeryung Kim; Se Woong Kang; Dong Hoon Shin; Sang Jin Kim; Ga Eun Cho
Journal:  Jpn J Ophthalmol       Date:  2015-08-01       Impact factor: 2.447

2.  Comparison and interchangeability of macular thickness measured with Cirrus OCT and Stratus OCT in myopic eyes.

Authors:  Geng Wang; Kun-Liang Qiu; Xue-Hui Lu; Ming-Zhi Zhang
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

3.  Fully automatic software for retinal thickness in eyes with diabetic macular edema from images acquired by cirrus and spectralis systems.

Authors:  Joo Yong Lee; Stephanie J Chiu; Pratul P Srinivasan; Joseph A Izatt; Cynthia A Toth; Sina Farsiu; Glenn J Jaffe
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-15       Impact factor: 4.799

4.  Comment on "Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration".

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

5.  Calculating the predicted retinal thickness from spectral domain and time domain optical coherence tomography - comparison of different methods.

Authors:  Colin S Tan; Kelvin Z Li; Tock Han Lim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-27       Impact factor: 3.117

6.  Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye.

Authors:  Toke Bek; Sidsel Ehlers Klug
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-10       Impact factor: 3.117

7.  In vivo evaluation of the cornea and conjunctiva of the normal laboratory beagle using time- and Fourier-domain optical coherence tomography and ultrasound pachymetry.

Authors:  Ann R Strom; Dennis E Cortés; Carol A Rasmussen; Sara M Thomasy; Kim McIntyre; Shwu-Fei Lee; Philip H Kass; Mark J Mannis; Christopher J Murphy
Journal:  Vet Ophthalmol       Date:  2015-02-10       Impact factor: 1.644

8.  Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema.

Authors:  Susan B Bressler; Allison R Edwards; Kakarla V Chalam; Neil M Bressler; Adam R Glassman; Glenn J Jaffe; Michele Melia; David D Saggau; Oren Z Plous
Journal:  JAMA Ophthalmol       Date:  2014-09       Impact factor: 7.389

9.  Reproducibility of Optovue RTVue Optical Coherence Tomography Retinal Thickness Measurements and Conversion to Equivalent Zeiss Stratus Metrics in Diabetic Macular Edema.

Authors:  Susan B Bressler; Allison R Edwards; Christopher M Andreoli; Paul Andrew Edwards; Adam R Glassman; Glenn J Jaffe; Michele Melia; Jennifer K Sun
Journal:  Transl Vis Sci Technol       Date:  2015-01-22       Impact factor: 3.283

10.  One-Year Outcomes of the SAVE Study: Sirolimus as a Therapeutic Approach for UVEitis.

Authors:  Mohamed A Ibrahim; Yasir J Sepah; Anthony Watters; Millena Bittencourt; Erin M Vigil; Diana V Do; Quan Dong Nguyen
Journal:  Transl Vis Sci Technol       Date:  2015-03-10       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.